🇺🇸 FDA
Patent

US 11571485

Peptides and antibodies for detecting changes in alzheimer's disease brain and methods of use thereof

granted A61KA61K2039/505A61K38/00

Quick answer

US patent 11571485 (Peptides and antibodies for detecting changes in alzheimer's disease brain and methods of use thereof) held by SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE expires Mon Feb 02 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE
Grant date
Tue Feb 07 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 02 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61K, A61K2039/505, A61K38/00, A61K49/14, A61P